Ellen Rae Cooper, MD
Professor
Boston University School of Medicine
Dept of Pediatrics
Infectious Diseases

MD, University of Cincinnati College of Medicine
MA, Johns Hopkins University



Dr. Ellen Cooper is Professor of Pediatrics at Boston University School of Medicine, and is in the Division of Pediatric Infectious Diseases at Boston Medical Center. She founded and still directs the Pediatric HIV Program which now also includes an Adolescent HIV Initiative. In addition she leads the Transition Program for older adolescents who are transitioning to adult care.

She has published widely on the subject of Pediatric HIV treatment and care. She was a principal investigator of a large US based study designed to answer questions surrounding the perinatal transmission of HIV, and this continues to be one of her special interests. She was one of the original members of the HIV Consensus Committee, whose purpose was to establish guidelines for the diagnosis and treatment of HIV infected infants in the US, and her expertise led her to focus also on treatment and care in a number of high burden and low resource countries. She has worked in sites in Uganda, Cameroon, South Africa, Zambia, and in Ethiopia.

She was a participant, trainer and advisor to curriculum development and implementation for the MTCT-Plus Programs in Africa, and served as a technical advisor for ICAP, Columbia in their efforts to establish a Center of Excellence for the care of HIV infected children in Zambia. She continues to be an active participant in the NIH sponsored IMPAACT Network.

Active Staff Hospital Privileges
Boston Medical Center
Pediatrics



2015-2017 TOP DOCS: Boston Magazine
2014 Committee on Pediatric AIDS of the AAP: Teaching Innovation Award for Course Development
2010 ICAP and Ethiopia: Recognition Award
2009 oston Combined Residency Program in Pediatrics for teaching: Recognition Award
2002 American Herpes Foundation: Teaching Trainee Scholarship
1999 IDSA for Participation on the Professional Development and Equity Committee: Recognition Award
1994 Pediatric AIDS Community: Recognition Award
1993 Pine Manor College: Anne P. Nicholson Distinguished Lecturer
1991 Haitian Community AIDS Project: Physician Merit Award
1987 Boston University: Housestaff Teaching Award


A Phase 2/3, open-label, multicenter, multi-cohort, 2-part study evaluating pharmacokinetics (PK), safety, and efficacy of once-daily cobicistat-boosted darunavir (DRV/co) administered with a backgrou
02/10/2014 - 02/03/2016 (PI)
Gilead Sciences, Inc.


A Phase 2/3 Multicenter, Open-label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (BR)
02/04/2014 - 01/31/2016 (PI)
Gilead Sciences, Inc.


A phase 2/3 open-label study of pharmacokinetics, safety and antiviral activity of the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxii fumarte single table regimen (STR) in HIV-1 infected a
10/01/2012 - 09/30/2014 (PI)
Gilead Sciences, Inc.


An open label prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir, Tamiflu, in the treatment of children 1 to 12 years of age with confirmed influenza
04/30/2010 - 09/30/2013 (PI)
Roche Pharmaceuticals


An open label prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu) in the treatment of infants less than one year of age with influenza infecti
08/01/2010 - 08/15/2013 (PI)
F. Hoffmann-La Roche, Ltd.


A Pivotal Phase 3 Study of MEDI-524 (Numax), an Enhanced Potency Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children
09/14/2004 - 12/31/2009 (PI)
MedImmune, Inc.


A Prospective, Non-Interventional Study to Evaluate the Incidence of Hospitalizations and Medically-Attended Lower Respiratory Tract Infection (MALRI) in Premature Infants 32 to 35 Weeks Gestational Age Who are Not Recommended to Receive Prophylaxis for R
12/22/2006 - 06/30/2007 (PI)
MedImmune, Inc.

RSV Outbreaks in the Boston Medical Center NICU: The Role of Palibizumab in Prevention
10/01/2002 - 09/30/2003 (PI)
MedImmune, Inc.



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Haffey M, Bellamy P, McLaud D, O’Brien A, Moloney C, Clarke D, Amo K, Spinale S, Cooper E, Pelton S. Achieving US Public Health metrics in care of youth with HIV. Presented at the HRSA Ryan White and Global HIV/AIDS Program National Meeting, Boston, MA. 2018.
     
  2. Epstein R, Penwill N, Clarke D, Hamilton S, Moses J, Cooper E. Reducing Delays to Antiretroviral Receipt in Children Prescribed Post Exposure Prophylaxis for HIV. Presented at ID Week, San Diego CA. 2017.
     
  3. Epstein R, Penwill N, Clarke D, Hamilton S, Horbowicz K, Dorfman D, Moses J, Cooper E. Reducing Delays to Receipt of PEP in the Pediatric Emergency Department: Meds in Hand and a Multidisciplinary Team Approach. Presented at the Quality Improvement and Safety Conference organized at Boston Medical Center and Boston University School of Medicine (winner of patient safety award) Boston, MA. 2017.
     
  4. Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. Pediatr Infect Dis J. 2017 Jan; 36(1):61-62.View Related Profiles. PMID: 27749654.
     
  5. Peluso AM, Harnish BA, Miller NS, Cooper ER, Fujii AM. Effect of young sibling visitation on respiratory syncytial virus activity in a NICU. J Perinatol. 2015 Aug; 35(8):627-30.View Related Profiles. PMID: 25836315; DOI: 10.1038/jp.2015.27;.
     
  6. Clarke DF, Moloney C, Cooper ER. Iatrogenic Cushing's Syndrome due to pharmacokinetic interaction of intra-ocular corticosteroids and lopinavir/ritonavir in an HIV- infected adolescent: A case report. J AIDS Clin. Res. 2014.
     
  7. Ojikutu B, Higgins-Biddle M, Greeson D, Phelps BR, Amzel A, Okechukwu E, Kolapo U, Cabral H, Cooper E, Hirschhorn LR. The association between quality of HIV care, loss to follow-up and mortality in pediatric and adolescent patients receiving antiretroviral therapy in Nigeria. PLoS One. 2014; 9(7):e100039.View Related Profiles. PMID: 25075742; PMCID: PMC4116117; DOI: 10.1371/journal.pone.0100039;.
     
  8. Chakraborty,R, Van Dyke, Flynn P, Aldrovandi G, ChadwickE, Cooper ER, et al. Committee on Pediatric AIDS, American Academy of Pediatrics Policy Statement Transitioning HIV-Infected Youth into Adult Health Care. Pediatrics. 2013; 132:192-197.
     
  9. Ojikutu D, Greeson D, Phelps B, Azeez A, Cabral H, Cooper E. Patient and Site Level Predictors of Loss to Follow up and Mortality in Pediatric and Adolescent Patients in The Nigerian National Program. XIX International HIV Conference, Washington, DC. 2012.
     
  10. Greeson D, Ojikitu B, Bolton C, Phelps B, Bubela P, Cabral H, Cooper, E. Challenges to 2010 Pediatric Guideline Implementation in Zambia. XIX International HIV Conference; Washington, DC. 2012.
     
Showing 10 of 138 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 138 publications over 34 distinct years, with a maximum of 12 publications in 1992

YearPublications
19831
19842
19861
19871
19883
19894
19904
19915
199212
19937
19944
19957
19966
19978
19987
199910
20008
20016
20021
20031
20043
20053
20064
20072
20083
20096
20105
20113
20123
20131
20142
20151
20173
20181

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
Contact for Mentoring:


670 Albany St Biosquare III
Boston MA 02118
Google Map


Cooper's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department